Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2022 Aug 14;51(5):887–895. doi: 10.1111/cdoe.12783

Talking about cancer: Patient responses to raising awareness of oral cancer in primary dental care

Suzanne E Scott 1,2,, Geanina Bruj 3, Shahryar Beheshti 3, Ruth Evans 2, Oluwatunmise Awojobi 2
PMCID: PMC10946823  PMID: 35964230

Abstract

Objectives

Dentists and other members of the dental team could raise awareness by talking about oral cancer during routine dental check‐ups. A communication guide has been developed to facilitate this. However, it has been suggested that discussions about oral cancer may raise patients' anxiety and this has been documented by dentists as a barrier to having these conversations. The current research aimed to investigate implementation of the communication guide and its impact on the dental patient.

Methods

A consecutive‐case sample of adult dental patients attending primary dental care for a routine NHS check‐up at one dental practice were invited to take part in the study via letter prior to their appointment. Consultations of participating patients (n = 77) were audio‐recorded. Before and after their appointment, patients were asked to rate their current anxiety via the six‐item version of Spielberger's State‐Trait Anxiety Inventory. Audio recordings of each consultation were reviewed by two raters to determine the extent to which the dentist covered the topics recommended in the communication guide.

Results

The dentist informed all patients that they were being checked for oral cancer, spoke about signs and symptoms, and discussed risk factors. However, they rarely recommended where help should be sought or addressed barriers to seeking help. Discussions took an average of 95 s. The extent to which oral cancer was discussed did not correlate with patients' post‐appointment anxiety. Patients made positive or neutral responses to the discussions. The few questions that were asked were easily addressed.

Conclusions

As findings are based on one dentist working at one practice, generalization of these results should be cautious. The study indicated that using an evidence‐based guide to talk about oral cancer did not appear to raise patients' anxiety in this practice population. This could help to increase awareness of oral cancer in the endeavour to facilitate early cancer diagnosis.

Keywords: communication, early diagnosis, fidelity, observation, oral cancer

1. INTRODUCTION

In the UK the number of people diagnosed with oral cancer is increasing. Between 2004–2006 and 2014–2016 incidence rates have increased by 22%. 1 Patients with a tumour detected at Stage I have an 85% five‐year survival, compared with 10% for those diagnosed at stage IV. 2 Identification and treatment at an advanced stage is often associated with significant health‐related impairments including speech, eating and disfigurement, all of which have a profound impact on the patient's quality of life. 3 In England, over 50% of cases of oral cancer are diagnosed at an advanced stage. 4 One explanation for the high occurrence of advanced stage oral cancer is delays in seeking help for symptoms. 5 Population‐based data indicates that in England, individuals subsequently diagnosed with oral or oropharyngeal cancer have the longest patient intervals (time from symptom onset to first consultation with a healthcare professional) compared with 27 other cancers. 6 Approximately 30% of patients wait more than 3 months before consulting a healthcare professional about signs of oral cancer. 5 Misinterpretation of symptoms, low cancer awareness, competing priorities and low perceived ability to access health care have been found to be key explanations for delayed presentation of oral cancer. 5 , 7 , 8 The general population possess poor knowledge about oral cancer, and some key points (such as signs, symptoms and risk factors) are not well understood. 9 , 10 , 11 In a recent survey, over 50% of participants could not identify the signs and symptoms of oral cancer, 63% identified smoking cigarettes as a cause of oral cancer but only 35% identified alcohol as a risk factor. 9 People at higher risk of oral cancer, such as smokers, may have lower awareness than that of non‐smokers. 12 It is therefore essential to develop successful methods to aid early presentation by raising awareness of oral cancer, helping patients evaluate oral symptoms and increasing their ability to receive help for symptoms in a timely manner. 13 , 14 , 15

Members of the dental team could have a key role in raising awareness of oral cancer. 16 For instance, dentists and dental hygienists screen patients for signs of oral cancer and when doing so could also talk to patients to raise awareness. 17 , 18 , 19 , 20 Yet, a household survey of a nationally representative sample of 3384 adults 11 found that only 7.1% of those surveyed reported that their dentist or doctor had spoken to them about oral cancer. Similarly, a cross‐sectional study of 184 adult dental patients indicated that a low proportion of participants were aware of being screened for oral cancer by their current dentist (14%) or ever (12%). 20 Data from the U.K. and U.S. indicate that dentists are often reluctant to tell patients they are performing an oral mucosal examination, and often avoid using the word ‘cancer’ altogether as they are concerned about alarming patients and do not believe patients would be interested in this health advice. 19 , 20 , 21 In contrast, research with patients indicates dental patients (including that those at risk of developing oral cancer) are in favour of discussing oral cancer with their dentist. 21 A dental patient survey indicated 92% wanted their dentist to inform them that they are being screened for oral cancer and 97% wanted to be supported to reduce their risk of developing the disease. 20

Given dentists' reluctance to raise the topic of oral cancer, finding ways to help the dental team talk to patients about oral cancer during a routine examination is important. 20 An evidence‐based communication guide, the ‘ABC(DE) of encouraging early diagnosis of mouth cancer in the general dental practice’ (Figure 1) offers clear guidance to equip dentists to communicate effectively about oral cancer with their patients. 22 , 23 The guide was developed and tested through consultation with key stakeholders including adult dental and medical patients, General Dental Practitioners, General Practitioners, specialists in Oral Medicine, Dental Public Health Practitioners and Health Psychologists. 18 , 20 , 24 The content of this guide is based on theory (e.g. Leventhal's Common Sense Model of Self‐regulation, Bandura's Social Cognitive Theory, see Model of Pathways to Treatment 25 ) and evidence about the reasons why people delay seeking help from a healthcare professional after noticing symptoms of mouth cancer, 5 , 13 , 14 alongside principles of effective communication as specified in the Calgary Cambridge Communication Guide. 26 It includes key messages in an easy‐to‐follow format for an interactive discussion about symptoms, the importance of early detection, and when and where to seek help should symptoms occur. More than just providing information to the patient, it ensures a patient‐centred brief discussion to allow for personally relevant information to be shared, increasing the likelihood that the patient will engage with the discussion and increase their awareness of oral cancer. The guide emphasizes the ‘three‐week rule’ to help patients evaluate the need for care and encourages the dentist to negotiate a personalized action plan of where to seek help should symptoms occur in the future, taking into account any perceived barriers to accessing care.

FIGURE 1.

FIGURE 1

Communication guide: the ABC(DE) of encouraging early diagnosis of mouth cancer in general dental practice.

Evaluation of training in the use of this guide found dentists reported fewer perceived barriers to communicating about oral cancer and became more confident to talk about oral cancer with patients after attending the training session. 23 However, there are questions surrounding implementation of the oral cancer communication guide into routine dental practice (i.e. how the guide is used or adapted in everyday practice). Even after training, some dentists still seemed concerned about raising patient anxiety; therefore, it is vital to obtain data on patients' responses to talking about oral cancer in the dental setting. This information is essential prior to initiating a wider roll out of the communication guide in primary dental care. The current study aimed to obtain this information by investigating the extent to which the oral cancer communication guide is implemented by the dental team (intervention fidelity delivery) and its impact on the dental patient (intervention fidelity receipt). 27 Specifically, the following research questions were addressed:

  1. How do patients respond to discussions about oral cancer in the dental practice? (fidelity receipt)
    1. Does talking about oral cancer raise anxiety?
    2. What questions do patients ask?
  2. How is the communication guide used in everyday practice? (fidelity delivery)
    1. Which topics of the communication guide are included in discussions about oral cancer?
    2. How long do discussions about oral cancer take?
    3. Do patient characteristics influence the extent to which a dentist talks to a patient about oral cancer?

2. METHODS

2.1. Study design

This observational study involved analysis of audio recordings from routine dental consultations in primary care linked with patient questionnaires completed before and after their appointment. Observation is the gold standard methodology to assess intervention fidelity delivery. 27 Adding patient report to this allows additional insight into fidelity receipt. 28

2.2. Participants

Participants were recruited from one primary care dental practice in South‐East London, England, UK, under the care of one primary care dentist who was familiar with the communication guide through a condensed session of the training described by Awojobi et al, (2016). 23 The practice treats both NHS and private patients, but only NHS patients were invited to take part in this study. Inclusion criteria for the study were: English‐speaking patients over 18 years of age who had a routine NHS dental check‐up (either as a new or existing patient) during the study period (6 weeks during August–September 2019).

2.3. Procedure

All patients who had booked a check‐up appointment during the study period (consecutive case sampling) were given a letter signed by the dentist and a detailed information sheet about the study. This was either mailed to their home address or given to them at the practice if they were booking an appointment in person. On the day of the appointment, the researcher approached the patient to discuss the study. Those wishing to take part were asked to provide written informed consent and then completed a pre‐appointment questionnaire in the waiting room. The appointment with the dentist was audio‐recorded using a digital recorder (Philips, DVT 4010). After the dental appointment, the dentist and patient reconfirmed their consent for use of the audio recording and participants completed a post‐appointment questionnaire.

The participants were initially told (in the information sheet) that the focus of the research was on ‘communication and anxiety’ rather than specifically about ‘communication about oral cancer and anxiety’. This was because raising the topic in advance could have affected the communication occurring in the consultation (e.g., the patient may ask the dentist about oral cancer, which they would not have normally done) thus affecting the results. Following the British Psychological Society's Code of Human Research Ethics, the researcher debriefed each participant following completion of the post‐appointment questionnaire and asked to confirm if they were still willing for their data to be included in the study. An information leaflet about oral cancer was provided to those who wanted further information. The study procedure received HRA approval as part of a larger study assessing the impact of training on dental practitioners (REF: 19/NE/0221; IRAS project ID:246499).

2.4. Measures

2.4.1. Questionnaires

The pre‐appointment questionnaire collected data on patients' state anxiety measured by the 6‐item Spielberger's State Trait Anxiety Indicator (STAI‐6). 29 The scale has been shown to be valid and reliable in a range of samples and is a commonly used measure of anxiety that distinguishes between anxiety as a general aspect of personality (trait anxiety) and anxiety as a response to a specific situation (state anxiety). The STAI has been shown to be sensitive to change in anxiety even over a short duration. 29 , 30 , 31 Scores range from 6 to 24 with higher scores indicating higher anxiety. For two patients with missing data (each missed one item), scores were pro‐rated. The Cronbach alpha coefficient was 0.67 for the STAI‐6 pre‐appointment and 0.75 for the STAI‐6 post‐appointment.

The pre‐appointment questionnaire also measured dental anxiety (via the Modified Dental Anxiety Scale [MDAS]), 32 current level of pain (no pain, some pain, considerable pain or pain which could not be more severe), socio‐demographic details (age, sex, NHS status), medical history, alcohol consumption using the 3‐item Alcohol Use Disorders Identification Test Consumption (AUDIT‐C) 33 , 34 and tobacco use. The post‐appointment questionnaire collected current level of pain in addition to the STAI‐6. All questionnaires were piloted for face validity and ease of comprehension by five dental patients at a dental hospital.

2.5. Analysis

2.5.1. Audio‐recordings

Topics discussed: Two researchers (GB, KS) independently listened to each audio recording to determine which of the topics in the communication guide were discussed in each consultation. The researchers used a checklist of the 10 topics with clear definitions for each topic. Each researcher indicated whether the topic was or was not included in the consultation. Overall, there was 95% agreement between the two raters across the 10 topics. For the 5% where there was disagreement, a third researcher (SES) rated the verbatim transcript to reach final agreement. The agreed ratings were used to generate a measure of number of topics discussed (range 0–10) for each participant.

Duration: Two researchers (GB, SES) listened to each audio recording to determine the duration of each discussion about oral cancer (measured in seconds) within each appointment.

Patient responses: One researcher (RE) analysed the anonymized verbatim transcripts of the audio recordings to monitor patient's verbal responses to discussions about oral cancer. Using deductive thematic coding, the researcher determined if patient responses to the initial discussion about oral cancer were positive, negative or neutral. In addition, all patient questions in response to the discussion about oral cancer were identified. In acknowledging the coding of responses is subjective, the initial coding was then checked and confirmed by a second researcher (SES) to ensure credibility of the analysis.

2.5.2. Statistical analysis

Statistical data analysis was conducted using SPSS version 27. KS‐Lilliefors tests indicated non‐normal distribution of STAI‐6, the number of topics discussed and duration of discussions, therefore non‐parametric tests were used in analyses. A Wilcoxon Signed test was used to evaluate differences in STAI‐6 scores before and after the appointment. Based on the effect size of 0.3 (medium), alpha of 0.05 and a power to detect differences at 80%, a sample size of 82 participants was required to detect differences in anxiety over time.

Spearman rank correlation coefficients were calculated as a measure of the association between levels of state anxiety after the consultation and the number of topics discussed. Spearman rank correlation coefficients were also used to determine associations between patient characteristics and number of topics discussed, and state anxiety after the appointment. Due to multiple correlation calculations, statistical significance was considered at p < .01 to protect from type 1 error.

3. RESULTS

3.1. Participant characteristics

One hundred and six patients were eligible for inclusion during the six weeks study period. Of these, six did not attend. Consent to take part in the study (from both patient and dentist) was obtained for 80 patients. Adequate audio recordings were acquired for 77 (96%) of these participants. No participants withdrew their data after the debriefing. Table 1 summarizes the characteristics of the participants. The age of the participants ranged from 18 to 89 years (mean = 49.1 years; SD = 21.0). Most participants (n = 71, 92%) were paying for their NHS dental treatment. The remainder were either exempt due to pregnancy (n = 3, 4%) or being in receipt of income benefits (n = 3, 4%). Current tobacco use was reported by 7 participants (9%). Twenty participants (26%) reported former tobacco use and 52 (65%) participants had never smoked. Eleven participants (14%) did not consume alcohol. Twenty‐two participants (29%) had an alcohol intake indicative of risk of dependence as measured by the AUDIT‐C (mean Audit‐C score = 3.2; SD = 2.0). Scores on the Modified Dental Anxiety Scale ranged from 5 to 23 (mean = 11.1; SD 4.0). The majority (n = 45, 58%) were moderately anxious and 3 (4%) were very anxious, with levels akin with dental phobia.

TABLE 1.

Participant characteristics (N = 77)

Variable N % M (SD) Median
Age
18–39 yrs 32 42 49.1 (21.0) 51.0
40+ yrs 45 58
Sex
Female 41 53
Male 36 47
Alcohol (AUDIT‐C)
No alcohol consumption 11 14 3.2 (2.0) 3.0
Lower risk of alcohol dependence 44 57
Higher risk of alcohol dependence 22 29
Tobacco use
Never smoked 50 65
Used to smoke 20 26
Currently smoke 7 9
Pain before appointment
No pain 64 83
Some pain 8 10
Considerable pain 5 7
Pain after appointment
No pain 66 86
Some pain 8 10
Considerable pain 3 4
Dental Anxiety
Not dentally anxious (MDAS 5–9) 29 38 11.1(4.0) 11.0
Fairly dentally anxious (MDAS 10–18) 45 58
Very dentally anxious (MDAS 19+) 3 4
State anxiety (STAI‐6) before appointment 9.1 (2.6) 9.0
State anxiety (STAI‐6) after appointment 8.1 (2.8) 7.0
Medical history
No comorbidities 45 58
Anxiety or depression 13 17
Gastrointestinal condition 12 16
Joint or bone condition 8 10
Heart disease 5 7
Cancer 4 5
Lung disease 4 5
Diabetes 4 5

3.2. Talking about oral cancer

All consultations included a discussion about oral cancer to some extent. The dentist spoke to patients about oral cancer for between 34 and 193 s (mean = 95.2 s; SD = 34.5 s; median = 93.5 s). Sometimes, part of this discussion was during the intraoral examination (e.g. “So now I'm just checking in your mouth, the soft tissues for any lumps and bumps and red patches, white patches. And that looks … that's good” [P04]).

On average, the dentist discussed seven different topics with each patient when talking about oral cancer (Mean = 7.1 [SD = 0.9]; Median = 7.0; Range: 3–8 out of possible 10). Table 2 displays the extent to which each topic was discussed with patients. The dentist informed each patient that they were being screened for oral cancer, specifically using the word ‘cancer’. They also informed each patient of the main signs and symptoms of oral cancer. In the vast majority of appointments, the dentist also informed the patient about where in the mouth oral cancer can develop, the risk factors for oral cancer, and offered reassurance after the oral cancer screen (e.g. “So you've passed your cancer screening” [P068]).

TABLE 2.

Frequency with which each topic of the communication guide was discussed

Topic Consultations in which topic was discussed
N (%)
A Actually say ‘cancer’ 77 100
Reassurance [or referral] after screening 72 94
B Asking about patient's prior knowledge 65 84
Sign and symptoms of oral cancer 77 100
C Three‐week rule for symptoms 68 88
Where to seek help for symptoms 1 1
D Where oral cancer can develop 76 99
Risk / Risk factors for oral cancer 73 95
Finding mouth cancer early saves lives 41 53
E Barriers to seeking help 0 0

Red, Yellow, Green, Purple, Blue are encouraging early diagnosis of mouth cancer in general dental practice.

The dentist varied in the extent to which they encouraged the conversation to be interactive, with 84% of patients being asked what they knew prior to a discussion of signs and symptoms. Specific advice on the duration of symptoms (three‐week rule) was included in 88% of consultations. Topics that were rarely discussed were ‘where to seek help for symptoms’ (1%) and ‘barriers to seeking help’ (0%).

3.3. Talking about oral cancer and patient anxiety

The average level of state anxiety was lower after the appointment (median STAI‐6 = 7.0) compared to before the appointment (median STAI‐6 = 9.0; z = −2.83, p < .01).

There was no correlation between the number of oral cancer topics discussed and patient state anxiety after the appointment (Spearman's Rho = 0.13, p = .128) or between the number of oral cancer topics discussed and the change in state anxiety pre‐ to post‐appointment (Spearman's Rho = 0.02, p = .422, N = 74).

Table 3 summarizes associations between patient characteristics and number of topics discussed and state anxiety after the appointment. Smoking status was the only factor associated with the number of oral cancer topics discussed (Spearman's Rho = 0.27, p < .01). The dentist discussed more oral cancer topics with patients who smoked or used to smoke. The dentist discussed fewer oral cancer topics with patients who had a history of cancer, and more topics with those who had history of anxiety or depression, but these associations were only significant at the p < .05 level (Spearman's Rho = 0.21, p < .05).

TABLE 3.

Factors associated with number of topics discussed and state anxiety

Variable Association with number of topics discussed Association with state anxiety (STAI‐6) after the appointment
Spearman's Rho p Spearman's Rho p
Age (yrs) −0.05 .333 −0.07 .281
Sex a 0.10 .195 0.11 .171
Alcohol consumption (AUDIT‐C score) 0.12 .152 0.17 .066
Smoking a 0.27 <.01 0.10 .190
Pain before appointment a −0.05 .345 0.20 .041
Medical History a
Heart disease 0.02 .443 −0.05 .348
Cancer −0.21 .032 0.11 .169
Lung disease 0.17 .067 −0.05 .341
Joint or bone condition −0.04 .371 0.02 .444
Gastrointestinal condition −0.17 .074 −0.10 .197
Diabetes 0.004 .485 −0.08 .238
Anxiety or Depression 0.21 .035 −0.02 .426
Dental anxiety (MDAS) 0.001 .498 0.21 .034
State anxiety (STAI‐6) before appointment 0.08 .246 0.31 <.01
State anxiety (STAI‐6) after appointment 0.13 .128
a

Categorical variables were dichotomized as follows for analysis: Sex: 0 = female; 1 = male Smoking: 0 = never smoked; 1 = currently smoke or used to smoke Pain before appointment: 0 = no pain; 1 = some or considerable pain medical history: 0 = no history of condition; 1 = presence of condition.

State anxiety before the appointment was associated with state anxiety after the appointment (Spearman's Rho = 0.31, p < .01). Those who were more anxious prior to the appointment were more anxious after the appointment. Dental anxiety was associated with state anxiety after the appointment, but not at the p < .01 level (Spearman's Rho = 0.21, p < .05).

3.4. Patient responses to talking about oral cancer

Patient's initial responses to hearing about oral cancer screening were either short neutral replies (n = 39, 51%) such as “okay”, “fine,” “right” or positive comments (n = 17, 22%) such as “My goodness dentistry has really come on” [P008]; “Okay. That's brilliant” [P014]; “Sure, that sounds good.” [P028]. The remaining 22 patients (27%) gave no audible response. No patients reacted negatively to the discussion.

Patient questions were unprompted rather than invited by the dentist. There were relatively few (n = 8) patient questions in response to talking about oral cancer screening. Those that were asked related to either the novelty of screening for oral cancer (n = 4) e.g. “Is it something new?” [P046]; their own symptoms (n = 3), for example, “I've got sore bit just here, um and there” [P104]; or risk factors for oral cancer (n = 1), for example, “What is the age that's vulnerable for mouth cancer?” [P029].

4. DISCUSSION

A key objective of this study was to investigate how patients respond to conversations about oral cancer in routine dental consultations. To our knowledge, this is the first study that has done so, and one of the few studies that has collected enriched data on dentist–patient communication by audio‐recording routine dental appointments in general dental practice. Reassuringly, conversations about oral cancer did not appear to have impact on the level of patient anxiety. Rather than discussion about oral cancer, it was state anxiety before the appointment that was associated with state anxiety after the appointment: those patients who were anxious to begin with were more likely to be anxious after the appointment. Patients with risk factors for cancer (e.g., smoking, alcohol, advancing age) had similar levels of anxiety to those without risk factors, even after a discussion about oral cancer took place, although we are mindful that there were only a small number of patients who currently smoked in the sample. State anxiety levels were lower after the appointment compared with prior to the appointment. This does not necessarily mean that the oral cancer discussion led to the decrease in anxiety. However, it is reasonable to conclude that when the dentist talked about oral cancer it did not lead to an increase in anxiety. Patients were accepting of the discussion about oral cancer, with many commenting that it was a good initiative. This supports previous findings that dental patients want to be informed 20 and that cancer screening and awareness interventions may result in lower levels of anxiety. 22 , 35 , 36

Dentists have previously raised concerns that they may not have time or sufficient knowledge to answer patient questions that are raised following a discussion about oral cancer. 18 However, this study indicates that patient questions are infrequent, and on topics that can be answered without problem. In addition, the discussion about oral cancer can be combined with the oral cancer screening, thus limiting the impact of adding a discussion about oral cancer to already time‐limited consultations.

Audio‐recording the consultations enabled insight into how the dentist spoke about oral cancer as well as the patients' reactions, enabling assessment of fidelity delivery and receipt. The dentist included many of the communication guide topics apart from encouraging help‐seeking should patients notice symptoms in the future—either in terms of whom to seek help from or ways to overcome barriers to seek help. Training sessions in the use of the communication guide should consider this as an area of focus. This study found that the dentist adjusted the discussion about oral cancer in light of a patient's smoking status, with a more extensive discussion with those who have or used to smoke, as recommended in the communication guide. No other patient characteristics appeared to influence the extent to which the dentist talked to patient about oral cancer, indicating equity in implementation of the intervention.

The main limitation of the study is that the findings are restricted to one dentist who may not be representative of others, whom may have different level of experience, communication skills or practice settings. Other limitations include lack of a control group for whom oral cancer was not discussed, and absence of data on additional patient characteristics (e.g. socio‐economic status, ethnicity) that may have influenced outcome measures. The sample size was also five participants short of that required for statistical power to detect differences. It may not be possible to generalize these results to other patients as the sample included a higher number of participants who reported moderate levels of dental anxiety (58%) compared with general population (36%) but fewer (4%) who reported being very dentally anxious compared with general population (12%). 37 The majority of the sample were patients with relatively low risk of oral cancer. This is not only a consideration for the results of this study but also the potential efficacy of the intervention, given those at high risk of oral cancer may not regularly attend the dentist. Further, as the focus of the analysis of audio recordings was on the topics of the dentist–patient communication about oral cancer, additional analysis focusing on the quality of communication may be useful. For instance, use of non‐verbal and paralinguistic communication and the extent to which the dentist made information provision personally relevant to engage the patient and aid memory.

Whilst recognizing these limitations, especially with regard to generalizability of the results, the study has demonstrated that the dentist was able to discuss oral cancer within the confines of a time‐pressured appointment and this did not raise patients' anxiety. The findings indicate that using an evidence‐based guide to talk about oral cancer does not appear to raise patients' anxiety and this should encourage endeavours to raise awareness of oral cancer within the dental practice. Future work could assess the effectiveness of the intervention on raising cancer awareness, including duration of impact. Wider implementation will require development of accessible training resources that support and motivate the dental team as well as ensuring practitioners have the skills and beliefs in their capabilities to incorporate talking about oral cancer into their daily practice. Of course, there are additional hurdles to encouraging early diagnosis within the dental setting, not least dental attendance and ensuring routine oral cancer screening for all adult patients. This is especially the case following the COVID‐19 pandemic where access to dentistry has been limited and inequalities exacerbated. 38 , 39

FUNDING INFORMATION

This research was funded by an Oral Health Innovations (OHI PreViser Award) Research grant, administered through the Oral & Dental Research Trust.

CONFLICT OF INTEREST

None.

ACKNOWLEDGEMENTS

This research was funded by an Oral Health Innovations (OHI PreViser Award) Research grant, administered through the Oral & Dental Research Trust. SES is co‐investigator of the multi‐institutional CanTest Collaborative, which is funded by Cancer Research UK (C8640/A23385). We also thank the dental patients and dental practice for facilitating this research and Klaudia Stanoch who assisted in coding the audio recordings.

Scott SE, Bruj G, Beheshti S, Evans R, Awojobi O. Talking about cancer: Patient responses to raising awareness of oral cancer in primary dental care. Community Dent Oral Epidemiol. 2023;51:887‐895. doi: 10.1111/cdoe.12783

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

REFERENCES

  • 1. Bosetti C, Carioli G, Santucci C, et al. Global trends in oral and pharyngeal cancer incidence and mortality. Int J Cancer. 2020;147(4):1040‐1049. [DOI] [PubMed] [Google Scholar]
  • 2. Lewis MAO. Mouth cancer: presentation, detection and referral in primary dental care. Br Dent J. 2018;225(9):833‐840. [DOI] [PubMed] [Google Scholar]
  • 3. Bachmann AS, Zaunbauer AC, Tolke AM, et al. Well‐being and quality of life among oral cancer patients ‐ psychological vulnerability and coping responses upon entering initial treatment. J Craniomaxillofac Surg. 2018;46(9):1637‐1644. [DOI] [PubMed] [Google Scholar]
  • 4. Public Health England . Oral Cancer in England. A report on incidence, survival and mortality rates of oral cancer in England, 2016 to 2016. 2020. Available at https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891699/Oral_cancer_report_170420.pdf [Accessed December 2021].
  • 5. Scott SE, Grunfeld EA, Main J, McGurk M. Patient delay in oral cancer: a qualitative study of patients' experiences. Psycho Oncol. 2006;15(6):474‐485. [DOI] [PubMed] [Google Scholar]
  • 6. Lyratzopoulos G, Saunders CL, Abel GA, et al. The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers. Br J Cancer. 2015;112(S1):S35‐S40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Rogers SN, Lowe D, Catleugh M, Edwards D. An oral cancer awareness intervention in community pharmacy. Br J Oral Maxillofac Surg. 2010;48(7):498‐502. [DOI] [PubMed] [Google Scholar]
  • 8. Onizawa K, Nishihara K, Yamagata K, Yusa H, Yanagawa T, Yoshida H. Factors associated with diagnostic delay of oral squamous cell carcinoma. Oral Oncol. 2003;39(8):781‐788. [DOI] [PubMed] [Google Scholar]
  • 9. Oral Health Foundation . State of Mouth Cancer UK Report 2020/2021. Available at https://www.dentalhealth.org/thestateofmouthcancer [Accessed December 2021].
  • 10. Boundouki G, Humphris G, Field A. Knowledge of oral cancer, distress and screening intentions: longer term effects of a patient information leaflet. Patient Educ Couns. 2004;53(1):71‐77. [DOI] [PubMed] [Google Scholar]
  • 11. West R, Alkhatib MN, McNeill A, Bedi R. Awareness of mouth cancer in Great Britain. Br Dent J. 2006;200:167‐169. [DOI] [PubMed] [Google Scholar]
  • 12. Humphris GM, Field EA. An oral cancer information leaflet for smokers in primary care: results from two randomised controlled trials. Community Dent Oral Epidemiol. 2004;32(2):143‐149. [DOI] [PubMed] [Google Scholar]
  • 13. Scott SE, McGurk M, Grunfeld E. Patient delay for potentially malignant oral symptoms. Eur J Oral Sci. 2008;116:141‐147. [DOI] [PubMed] [Google Scholar]
  • 14. Scott SE, Grunfeld EA, Auyeung V, McGurk M. Barriers and triggers to seeking help for potentially malignant oral symptoms: implications for interventions. J Public Health Dent. 2009;69(1):34‐40. [DOI] [PubMed] [Google Scholar]
  • 15. Mighell A, Gallagher J. Oral cancer – improving early detection and promoting prevention. Are you up to date? Br Dent J. 2012;213:297‐299. [DOI] [PubMed] [Google Scholar]
  • 16. Scully C, Kirby J. Statement on mouth cancer diagnosis and prevention. Br Dent J. 2014;216(1):37‐38. [DOI] [PubMed] [Google Scholar]
  • 17. British Dental Association . Opportunistic Oral cancer screening: a management strategy for dental practice. British Dental Association (BDA) Occasional Paper. 2000;6:1‐36. [Google Scholar]
  • 18. Awojobi O, Newton JT, Scott SE. Why don't dentists talk to patients about oral cancer? Br Dent J. 2015;218(9):537‐541. [DOI] [PubMed] [Google Scholar]
  • 19. Choi Y, Dodd V, Watson J, Tomar SL, Logan HL, Edwards H. Perspectives of African Americans and dentists concerning dentist‐patient communication on oral cancer screening. Patient Educ Couns. 2008;71(1):41‐51. [DOI] [PubMed] [Google Scholar]
  • 20. Awojobi O, Scott SE, Newton T. Patients' perceptions of oral cancer screening in dental practice: a cross‐sectional study. BMC Oral Health. 2012;12:55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Mariño R, Haresaku S, McGrath R, et al. Oral cancer screening practices of oral health professionals in Australia. BMC Oral Health. 2017;17(1):151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Scott SE, Khwaja M, Low EL, Weinman J, Grunfeld EA. A randomised controlled trial of a pilot intervention to encourage early presentation of oral cancer in high risk groups. Patient Educ Couns. 2012;88(2):241‐248. [DOI] [PubMed] [Google Scholar]
  • 23. Awojobi O, Newton JT, Scott SE. Pilot study to train dentists to communicate about oral cancer: the impact on dentists' self‐reported behaviour, confidence and beliefs. Br Dent J. 2016;220(2):71‐76. [DOI] [PubMed] [Google Scholar]
  • 24. Scott SE, Weinman J, Grunfeld EA. Developing ways to encourage early detection and presentation of oral cancer: what do high‐risk individuals think? Psychol Health. 2011;26:1392‐1405. [DOI] [PubMed] [Google Scholar]
  • 25. Scott SE, Walter FM, Webster A, Sutton S, Emery J. The model of pathways to treatment: conceptualization and integration with existing theory. Br J Health Psychol. 2013;18(1):45‐65. [DOI] [PubMed] [Google Scholar]
  • 26. Silverman J, Kurtz S, Draper J. Skills for Communicating with Patients. 3rd ed. CRC Press; 2013. [Google Scholar]
  • 27. Bellg AJ, Borrelli B, Resnick B, et al. Treatment Fidelity workgroup of the NIH behavior change consortium. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH behavior change consortium. Health Psychol. 2004;23(5):443‐451. [DOI] [PubMed] [Google Scholar]
  • 28. Walton H, Spector A, Tombor I, Michie S. Measures of fidelity of delivery of, and engagement with, complex, face‐to‐face health behaviour change interventions: a systematic review of measure quality. Br J Health Psychol. 2017;22(4):872‐903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Marteau TM, Bekker H. The development of a six‐item short‐form of the state scale of the Spielberger state‐trait anxiety inventory (STAI). Br J Clin Psychol. 1992;31(3):301‐306. [DOI] [PubMed] [Google Scholar]
  • 30. Abend R, Dan O, Maoz K, Raz S, Bar‐Haim Y. Reliability, validity and sensitivity of a computerized visual analog scale measuring state anxiety. J Behav Ther Exp Psychiatry. 2014;45(4):447‐453. [DOI] [PubMed] [Google Scholar]
  • 31. van der Bij AK, de Weerd S, Cikot RJ, Steegers EA, Braspenning JC. Validation of the dutch short form of the state scale of the Spielberger state‐trait anxiety inventory: considerations for usage in screening outcomes. Community Genet. 2003;6(2):84‐87. [DOI] [PubMed] [Google Scholar]
  • 32. Humphris GM, Dyer TA, Robinson PG. The modified dental anxiety scale: UKgeneral public population norms in 2008 with further psychometrics and effects of age. BMC Oral Health. 2009;9:20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Bradley KA, Debenedetti AF, Volk RJ, Williams E, Frank D, Kivlahan DR. Audit‐C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31:1208‐1217. [DOI] [PubMed] [Google Scholar]
  • 34. Babor TF, De La Fuente JR, Saunders J, Grant T. Audit ‐ the Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. World Health Organization; 1992. [Google Scholar]
  • 35. Humphris GM, Ireland RS, Field EA. Randomised trial of the psychological effect of information about oral cancer in primary care settings. Oral Oncol. 2001;37(7):548‐552. [DOI] [PubMed] [Google Scholar]
  • 36. Holloway RM, Wilkinson C, Peters TJ, et al. Cluster‐randomised trial of risk communication to enhance informed uptake of cervical screening. Br J Gen Pract. 2003;53(493):620‐625. [PMC free article] [PubMed] [Google Scholar]
  • 37. Nuttall N, Freeman R, Beavan‐Seymour C, Hill K. Access and Barriers to Care – a Report from the Adult Dental Health Survey 2009; 2011. Available at http://doc.ukdataservice.ac.uk/doc/6884/mrdoc/pdf/6884theme8_barriers_and_access_to_care.pdf [Accessed December 2021].
  • 38. General Dental Council . COVID‐19 and dentistry. Survey of the UKpublic for the general dental council; 2020. Available at https://www.gdc‐uk.org/about‐us/what‐we‐do/research/our‐research‐library/detail/report/covid‐19‐and‐dentistry‐survey‐of‐the‐uk‐public [Accessed December 2021].
  • 39. Stennett M, Tsakos G. The impact of the COVID‐19 pandemic on oral health inequalities and access to oral healthcare in England. Br Dent J. 2022;232:109‐114. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.


Articles from Community Dentistry and Oral Epidemiology are provided here courtesy of Wiley

RESOURCES